SPRO - Spero Therapeutics, Inc.
0.62
0.045 7.258%
Share volume: 81,463
Last Updated: 05-09-2025
Pharmaceutical Products/Pharmaceutical Preparations:
-0.09%
PREVIOUS CLOSE
CHG
CHG%
$0.58
0.05
0.08%
Summary score
30%
Profitability
25%
Dept financing
6%
Liquidity
50%
Performance
35%
Sector
Manufacturing
Industry
Pharmaceutical Products/Pharmaceutical Preparations
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-19.73%
Return on assets
-15.7%
Return on sales
0%
Return on invested capital
110.03%
Total debt ratio
15.6%
Debt ratio change over timeo
0%
Current Ratio
9.42%
Quick Ratio
0%
Cash Position Ratio
5.33%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-26.31%
Return on assets
-20.02%
Return on sales
0%
Return on invested capital
226.92%
Total debt ratio
24.19%
Debt ratio change over timeo
0%
Current Ratio
4.82%
Quick Ratio
0%
Cash Position Ratio
2.6%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-23.74%
Return on assets
-18.94%
Return on sales
0%
Return on invested capital
259.16%
Total debt ratio
24.43%
Debt ratio change over time
0%
Current Ratio
4.49%
Quick Ratio
0%
Cash Position Ratio
3.44%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SPRO | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -19.73% | 17.45% | 4.69% | 19.89% |
| Return on assets | -15.7% | 3.37% | 3.35% | 11.41% |
| Return on sales | 0% | 23.96% | 25.96% | 42.05% |
| Return on invested capital | 110.03% | 5.2% | 4.37% | -272.99% |
| Profitability | 25% | 45% | 30% | 75% |
| Total debt ratio | 15.6% | 77% | 57.66% | 53.92% |
| Debt ratio change over time | 0% | 0% | 10.55% | 0% |
| Dept financing | 5% | 25% | 44% | 18% |
| Current Ratio | 4.82% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 2.6% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 25% | 32% | 20% |
| Short-term ratios | SPRO | LLY | JNJ | NVO |
|---|---|---|---|---|
| Return on equity | -26.31% | 44.06% | 6.24% | 17.3% |
| Return on assets | -20.02% | 3.88% | 3.22% | 9.33% |
| Return on sales | 0% | 27.04% | 24.93% | 40.02% |
| Return on invested capital | 226.92% | 9.69% | 4.96% | -224.06% |
| Profitability | 25% | 53% | 28% | 60% |
| Total debt ratio | 24.19% | 91.8% | 61.39% | 55.88% |
| Debt ratio change over time | 0% | 0% | 12.93% | 0% |
| Dept financing | 7% | 25% | 42% | 15% |
| Current Ratio | 4.82% | 1.16% | 1.27% | 1.05% |
| Quick Ratio | 0% | 0.89% | 1.01% | 0.77% |
| Cash Position Ratio | 2.6% | 0.17% | 0.53% | 0.31% |
| Liquididy | 50% | 30% | 37% | 27% |
